Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of adverse reactions of two rabies vaccines
IRCT2015102124470N1Phase 2Completed
- Sponsor
- Center of Disease Control (CDC), Ministry of Health, Tehran, Iran
- Start
- Dec 2011
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of Rabies vaccine in rabies (2 arms), sponsored by Center of Disease Control (CDC), Ministry of Health, Tehran, Iran. Primary endpoint: Adverse reactions. Started Dec 2011; status: completed.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on IRCT2015102124470N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015102124470N1.